Published in Emerg Infect Dis on February 01, 2009
Bats, emerging infectious diseases, and the rabies paradigm revisited. Emerg Health Threats J (2011) 1.32
Diseases and causes of death in European bats: dynamics in disease susceptibility and infection rates. PLoS One (2011) 1.05
A preliminary study of viral metagenomics of French bat species in contact with humans: identification of new mammalian viruses. PLoS One (2014) 1.02
Cross sectional survey of human-bat interaction in Australia: public health implications. BMC Public Health (2014) 0.94
Lyssavirus detection and typing using pyrosequencing. J Clin Microbiol (2011) 0.94
A two-step lyssavirus real-time polymerase chain reaction using degenerate primers with superior sensitivity to the fluorescent antigen test. Biomed Res Int (2014) 0.85
Ecological factors associated with European bat lyssavirus seroprevalence in spanish bats. PLoS One (2013) 0.85
European bats as carriers of viruses with zoonotic potential. Viruses (2014) 0.81
Cross-Species Transmission and Differential Fate of an Endogenous Retrovirus in Three Mammal Lineages. PLoS Pathog (2015) 0.80
Intergenotypic replacement of lyssavirus matrix proteins demonstrates the role of lyssavirus M proteins in intracellular virus accumulation. J Virol (2009) 0.79
Comparative studies on the genetic, antigenic and pathogenic characteristics of Bokeloh bat lyssavirus. J Gen Virol (2014) 0.77
Enhanced passive bat rabies surveillance in indigenous bat species from Germany--a retrospective study. PLoS Negl Trop Dis (2014) 0.77
Insights into persistence mechanisms of a zoonotic virus in bat colonies using a multispecies metapopulation model. PLoS One (2014) 0.77
Effect of media warnings on rabies postexposure prophylaxis, France. Emerg Infect Dis (2011) 0.75
Computational analysis suggests that lyssavirus glycoprotein gene plays a minor role in viral adaptation. Int J Evol Biol (2011) 0.75
Bat rabies in France: a 24-year retrospective epidemiological study. PLoS One (2014) 0.75
Comparative analysis of European bat lyssavirus 1 pathogenicity in the mouse model. PLoS Negl Trop Dis (2017) 0.75
WHO Expert Consultation on rabies. World Health Organ Tech Rep Ser (2005) 3.79
Genomic diversity and evolution of the lyssaviruses. PLoS One (2008) 1.98
Phylogeography, population dynamics, and molecular evolution of European bat lyssaviruses. J Virol (2005) 1.51
Spill-over of European bat lyssavirus type 1 into a stone marten (Martes foina) in Germany. J Vet Med B Infect Dis Vet Public Health (2004) 1.37
Temporal dynamics of European bat Lyssavirus type 1 and survival of Myotis myotis bats in natural colonies. PLoS One (2007) 1.27
Rabies in Europe in 2005. Euro Surveill (2005) 1.15
Natural and experimental infection of sheep with European bat lyssavirus type-1 of Danish bat origin. J Comp Pathol (2006) 1.04
A simple sandwich ELISA (WELYSSA) for the detection of lyssavirus nucleocapsid in rabies suspected specimens using mouse monoclonal antibodies. Biologicals (2007) 0.93
Susceptibility of sheep to European bat lyssavirus type-1 and -2 infection: a clinical pathogenesis study. Vet Microbiol (2007) 0.93
Antibodies to EBLV-1 in a domestic cat in Denmark. Vet Rec (2004) 0.89
Public health risk analysis of European bat lyssavirus infection in The Netherlands. Epidemiol Infect (2008) 0.84
Genome evolution in yeasts. Nature (2004) 10.50
Organised genome dynamics in the Escherichia coli species results in highly diverse adaptive paths. PLoS Genet (2009) 8.51
Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet (2005) 8.30
Sequencing of Aspergillus nidulans and comparative analysis with A. fumigatus and A. oryzae. Nature (2005) 7.74
Evidence in the Legionella pneumophila genome for exploitation of host cell functions and high genome plasticity. Nat Genet (2004) 4.93
Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet (2013) 4.57
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. N Engl J Med (2015) 4.26
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection. N Engl J Med (2008) 3.71
Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer. Genome Res (2007) 3.45
Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc Natl Acad Sci U S A (2010) 2.79
Genome of the host-cell transforming parasite Theileria annulata compared with T. parva. Science (2005) 2.55
Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clin Infect Dis (2003) 2.54
Genome sequence of the saprophyte Leptospira biflexa provides insights into the evolution of Leptospira and the pathogenesis of leptospirosis. PLoS One (2008) 2.35
Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense. PLoS Genet (2009) 2.35
Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Soc Sci Med (2002) 2.33
Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Malar J (2009) 2.33
The origin and phylogeography of dog rabies virus. J Gen Virol (2008) 2.23
Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen. AIDS (2002) 2.21
Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Crit Care Med (2007) 2.03
Evolutionary history and dynamics of dog rabies virus in western and central Africa. J Gen Virol (2009) 1.98
Genomic diversity and evolution of the lyssaviruses. PLoS One (2008) 1.98
Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen. J Infect Dis (2002) 1.90
Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1. PLoS Med (2004) 1.89
Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes. Antimicrob Agents Chemother (2008) 1.86
Parallel independent evolution of pathogenicity within the genus Yersinia. Proc Natl Acad Sci U S A (2014) 1.83
Phylodynamics and human-mediated dispersal of a zoonotic virus. PLoS Pathog (2010) 1.83
Phi29 polymerase based random amplification of viral RNA as an alternative to random RT-PCR. BMC Mol Biol (2008) 1.81
Microcyclamide biosynthesis in two strains of Microcystis aeruginosa: from structure to genes and vice versa. Appl Environ Microbiol (2008) 1.79
Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening. PLoS One (2011) 1.79
Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility. Antimicrob Agents Chemother (2009) 1.70
Genomic analysis of smooth tubercle bacilli provides insights into ancestry and pathoadaptation of Mycobacterium tuberculosis. Nat Genet (2013) 1.67
Highly plastic genome of Microcystis aeruginosa PCC 7806, a ubiquitous toxic freshwater cyanobacterium. BMC Genomics (2008) 1.66
Genetic constraints and the adaptive evolution of rabies virus in nature. Virology (2002) 1.65
Evaluation of high-throughput sequencing for identifying known and unknown viruses in biological samples. J Clin Microbiol (2011) 1.64
Genome sequence of Streptococcus gallolyticus: insights into its adaptation to the bovine rumen and its ability to cause endocarditis. J Bacteriol (2010) 1.64
European bat lyssavirus infection in Spanish bat populations. Emerg Infect Dis (2002) 1.63
Countrywide survey shows very high prevalence of Plasmodium falciparum multilocus resistance genotypes in Cambodia. Antimicrob Agents Chemother (2005) 1.63
Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy. Clin Infect Dis (2002) 1.57
Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up study. Antivir Ther (2003) 1.55
Phylogeography, population dynamics, and molecular evolution of European bat lyssaviruses. J Virol (2005) 1.51
Invasion of Africa by a single pfcrt allele of South East Asian type. Malar J (2006) 1.51
Analysis of the Legionella longbeachae genome and transcriptome uncovers unique strategies to cause Legionnaires' disease. PLoS Genet (2010) 1.46
Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults. AIDS (2009) 1.46
A reliable diagnosis of human rabies based on analysis of skin biopsy specimens. Clin Infect Dis (2008) 1.45
Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use. PLoS One (2007) 1.44
Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity. AIDS (2008) 1.42
Efficacy and safety of emtricitabine vs stavudine in combination therapy in antiretroviral-naive patients: a randomized trial. JAMA (2004) 1.42
Infectious causes of encephalitis. Lancet Infect Dis (2010) 1.41
Stress by heat shock induces massive down regulation of genes and allows differential allelic expression of the Gal/GalNAc lectin in Entamoeba histolytica. Eukaryot Cell (2006) 1.40
Risk factors for leptospirosis in metropolitan France: results of a national case-control study, 1999-2000. Clin Infect Dis (2004) 1.39
Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data. J Antimicrob Chemother (2009) 1.39
Rabies, still neglected after 125 years of vaccination. PLoS Negl Trop Dis (2010) 1.36
Country-wide assessment of the genetic polymorphism in Plasmodium falciparum and Plasmodium vivax antigens detected with rapid diagnostic tests for malaria. Malar J (2008) 1.34
Evolutionary genetic dissection of human interferons. J Exp Med (2011) 1.32
The evolutionary history and dynamics of bat rabies virus. Infect Genet Evol (2006) 1.32
Serologic evidence of lyssavirus infection in bats, Cambodia. Emerg Infect Dis (2004) 1.31
Comparison of widely used Listeria monocytogenes strains EGD, 10403S, and EGD-e highlights genomic variations underlying differences in pathogenicity. MBio (2014) 1.29
Genome sequence of Vibrio splendidus: an abundant planctonic marine species with a large genotypic diversity. Environ Microbiol (2009) 1.29
Efficacy and tolerability of a nucleoside reverse transcriptase inhibitor-sparing combination of lopinavir/ritonavir and efavirenz in HIV-1-infected patients. J Acquir Immune Defic Syndr (2005) 1.29
Clinical management of treatment-experienced, HIV-infected patients with the fusion inhibitor enfuvirtide: consensus recommendations. AIDS (2004) 1.28
Rabies situation in Cambodia. PLoS Negl Trop Dis (2009) 1.28
Temporal dynamics of European bat Lyssavirus type 1 and survival of Myotis myotis bats in natural colonies. PLoS One (2007) 1.27
Massively parallel pathogen identification using high-density microarrays. Microb Biotechnol (2008) 1.26
Gemini: a noninferiority study of saquinavir/ritonavir versus lopinavir/ritonavir as initial HIV-1 therapy in adults. J Acquir Immune Defic Syndr (2009) 1.25
Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine. Malar J (2008) 1.25
Plasmodium knowlesi infection in humans, Cambodia, 2007-2010. Emerg Infect Dis (2011) 1.23
Switch from enfuvirtide to raltegravir in virologically suppressed multidrug-resistant HIV-1-infected patients: a randomized open-label trial. Clin Infect Dis (2009) 1.23
Point-of-care ultrasound in intensive care units: assessment of 1073 procedures in a multicentric, prospective, observational study. Intensive Care Med (2015) 1.22
Renewed global partnerships and redesigned roadmaps for rabies prevention and control. Vet Med Int (2011) 1.22
Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa. Am J Trop Med Hyg (2010) 1.18
Signatures of purifying and local positive selection in human miRNAs. Am J Hum Genet (2009) 1.18
Imported episodic rabies increases patient demand for and physician delivery of antirabies prophylaxis. PLoS Negl Trop Dis (2010) 1.17
Protease inhibitor resistance analysis in the MONARK trial comparing first-line lopinavir-ritonavir monotherapy to lopinavir-ritonavir plus zidovudine and lamivudine triple therapy. Antimicrob Agents Chemother (2009) 1.17
The gas vesicle gene cluster from Microcystis aeruginosa and DNA rearrangements that lead to loss of cell buoyancy. J Bacteriol (2004) 1.17
Insertion site preference of Mu, Tn5, and Tn7 transposons. Mob DNA (2012) 1.17
Geographic structuring of the Plasmodium falciparum sarco(endo)plasmic reticulum Ca2+ ATPase (PfSERCA) gene diversity. PLoS One (2010) 1.17
Application of broad-spectrum resequencing microarray for genotyping rhabdoviruses. J Virol (2010) 1.16
From array-based hybridization of Helicobacter pylori isolates to the complete genome sequence of an isolate associated with MALT lymphoma. BMC Genomics (2010) 1.16
A mannan binding lectin is involved in cell-cell attachment in a toxic strain of Microcystis aeruginosa. Mol Microbiol (2006) 1.16
Loss of heterozygosity in commensal isolates of the asexual diploid yeast Candida albicans. Fungal Genet Biol (2008) 1.14
Lyssavirus matrix protein induces apoptosis by a TRAIL-dependent mechanism involving caspase-8 activation. J Virol (2004) 1.14
Rafts promote assembly and atypical targeting of a nonenveloped virus, rotavirus, in Caco-2 cells. J Virol (2002) 1.14
Recent emergence and spread of an Arctic-related phylogenetic lineage of rabies virus in Nepal. PLoS Negl Trop Dis (2013) 1.12
Introduction of SARS in France, March-April, 2003. Emerg Infect Dis (2004) 1.10
Rhabdovirus matrix protein structures reveal a novel mode of self-association. PLoS Pathog (2008) 1.10
Chloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in Madagascar. PLoS One (2010) 1.09
A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods. PLoS Negl Trop Dis (2008) 1.08
Identification and characterization of the genetic changes responsible for the characteristic smooth-to-rough morphotype alterations of clinically persistent Mycobacterium abscessus. Mol Microbiol (2013) 1.07
More accurate insight into the incidence of human rabies in developing countries through validated laboratory techniques. PLoS Negl Trop Dis (2010) 1.07
Plasticity and evolution of aeruginosin biosynthesis in cyanobacteria. Appl Environ Microbiol (2009) 1.06
The complete mitochondrial genome sequence of the pathogenic yeast Candida (Torulopsis) glabrata. FEBS Lett (2003) 1.06